How Dr Reddy’s is rebooting its biosimilars playDr Reddy’s was among the first to race off the blocks with four launches in India about as many years. But things have slowed since.
29 Sep, 2015, 02.51 AM IST
Intas cuts Razumab supplies after adverse eye reactionsRazumab, a biosimilar of Genentech’s Lucentis, was launched in June at about 25 per cent cheaper than the innovator drug marketed by Novart...
21 Aug, 2015, 04.00 AM IST
Intas Pharmaceuticals to launch its first biosimilar in US in 9-12 monthsIntas is the only domestic firm with two biosimilars filed for registration in the US and it looks to deliver affordable and innovative pha...
21 Jun, 2015, 01.54 PM IST
- Novartis posts 10 pc drop in Q2 net profit
Novartis AG posted 10 percent drop in second quarter net profit due to shifts in currency values and higher financing costs, but said under...
16 Jul, 2009, 03.04 PM IST
- Novartis buys stake in Nestle eyecare unit for $11 bn
Nestle based in Switzerland said it would use the funds from the divestment to support opportunities for growth. Go nutty for health | In P...
07 Apr, 2008, 03.33 PM IST
- Novartis may route new drugs through subsidiary
Contrary to investor expectations, Novartis may launch some of its new-patented drugs in India through its wholly-owned subsidiary.
20 Dec, 2006, 12.02 AM IST